Blog
Trinity: Deep Dive
The AI Context Layer: The Missing Link in AI-Ready Data
Most commercial life sciences organizations have invested heavily in data. They have lakehouses, harmonized data feeds, and dashboard environments like Power BI, Tableau, and Snowflake that teams rely on daily. These tools already carry semantic models: metric definitions, schema relationships, and governed sources. The analytics infrastructure is real. Yet when they try to build AI on top of it, they hit the same wall: the AI doesn’t understand their business.
Filter posts by:
Blog
From Patent Cliff to AI Gaps: Six Commercialization Challenges Shaping Pharma in 2026
Trinity recently convened its leadership team to examine the scale of the industry’s current commercialization challenges and stress test the solutions we are bringing to clients. Our senior leadership articulated the six most material issues facing biopharma today and created space...
Trinity: Deep Dive
From Static Insights to Always On Intelligence
There is a growing paradox in life sciences commercialization: more data and more research than ever, yet many critical decisions still rely on static decks, siloed databases, and one time studies that go stale almost immediately. Commercial, medical, and market access...
Trinity: Deep Dive
The AI Context Layer: The Missing Link in AI-Ready Data
Most commercial life sciences organizations have invested heavily in data. They have lakehouses, harmonized data feeds, and dashboard environments like Power BI, Tableau, and Snowflake that teams rely on daily. These tools already carry semantic models: metric definitions, schema relationships, and...
Trinity: Deep Dive
De-Risk Market Access: Simulate Payer Decisions Before You Go to Market
Market access teams routinely make high-stakes decisions with incomplete information and compressed timelines. Primary market research remains the gold standard, but in-depth interviews with payers are expensive, logistically complex, and difficult to repeat iteratively as strategy and data evolves. The result...
Market Access Trends 2026
How China’s Layered Access System and Real-World Evidence Are Changing Market Access
China is evolving beyond a single public reimbursement model toward a layered access system that combines national coverage, commercial funding, and early access programs. In 2025, these changes began to reshape how manufacturers think about pricing, evidence, and launch sequencing. In...
Market Access Trends 2026
How Four Pillars Are Shaping Latin America and MENA Market Access
Latin American and MENA markets have long faced the challenge of balancing constrained public budgets with rising demand for newer therapies. In 2025, governments in these regions took concrete steps to modernize pricing rules, raise evidence expectations, expand partnership models, and...
